DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DCLK2 | Doublecortin-like kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
DMPK | Dystrophia myotonica-protein kinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DSTYK | Dual serine/threonine and tyrosine protein kinase | Enzymes
| | | | | Mixed |
DYRK1A | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
DYRK2 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DYRK4 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | Enzymes
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF2AK2 | Eukaryotic translation initiation factor 2-alpha kinase 2 | Enzymes
| | | | | Expressed in all |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPHA6 | EPH receptor A6 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERBB3 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ERN1 | Endoplasmic reticulum to nucleus signaling 1 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FASTK | Fas-activated serine/threonine kinase | Enzymes
| | | | | Expressed in all |
FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins
| | | | | Mixed |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
FYN | FYN oncogene related to SRC, FGR, YES | Enzymes Plasma proteins
| | | | | Expressed in all |
GAK | Cyclin G associated kinase | Enzymes
| | | | | Expressed in all |
GRK4 | G protein-coupled receptor kinase 4 | Enzymes
| | | | | Tissue enriched |
GRK5 | G protein-coupled receptor kinase 5 | Enzymes
| | | | | Expressed in all |
GRK6 | G protein-coupled receptor kinase 6 | Enzymes
| | | | | Expressed in all |
GSG2 | Germ cell associated 2 (haspin) | Enzymes
| | | | | Tissue enhanced |
GSK3A | Glycogen synthase kinase 3 alpha | Cancer-related genes Enzymes
| | | | | Expressed in all |
GSK3B | Glycogen synthase kinase 3 beta | Enzymes
| | | | | Expressed in all |
HIPK2 | Homeodomain interacting protein kinase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK3 | Homeodomain interacting protein kinase 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
HUNK | Hormonally up-regulated Neu-associated kinase | Enzymes
| | | | | Mixed |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKE | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | Enzymes
| | | | | Mixed |
ILK | Integrin-linked kinase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes
| | | | | Expressed in all |
IRAK4 | Interleukin-1 receptor-associated kinase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KSR1 | Kinase suppressor of ras 1 | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
LATS2 | Large tumor suppressor kinase 2 | Enzymes
| | | | | Expressed in all |
LCK | Lymphocyte-specific protein tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
LIMK1 | LIM domain kinase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LIMK2 | LIM domain kinase 2 | Enzymes
| | | | | Expressed in all |
LMTK2 | Lemur tyrosine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LRRK1 | Leucine-rich repeat kinase 1 | Enzymes
| | | | | Mixed |
LYN | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |